ARMISTICE CAPITAL, LLC - Q4 2016 holdings

$423 Million is the total value of ARMISTICE CAPITAL, LLC's 48 reported holdings in Q4 2016. The portfolio turnover from Q3 2016 to Q4 2016 was 100.0% .

 Value Shares↓ Weighting
BuySPDR S&P 500 ETF TRput$55,883,000
+7.6%
250,000
+4.2%
13.22%
-20.6%
ATRS SellANTARES PHARMA INC$25,630,000
+24.0%
11,000,000
-10.6%
6.06%
-8.6%
HAIN BuyHAIN CELESTIAL GROUP INC$14,831,000
+19.8%
380,000
+9.2%
3.51%
-11.7%
FRPT BuyFRESHPET INC$14,372,000
+79.8%
1,416,000
+53.2%
3.40%
+32.6%
PCRX BuyPACIRA PHARMACEUTICALS INC$12,920,000
+40.9%
400,000
+49.3%
3.06%
+3.8%
LVS BuyLAS VEGAS SANDS CORP$12,605,000
+54.3%
236,000
+66.2%
2.98%
+13.7%
ARLZ BuyARALEZ PHARMACEUTICALS INC$12,507,000
+22.8%
2,836,000
+35.0%
2.96%
-9.5%
NewVERIFONE SYS INCcall$12,411,000700,000
+100.0%
2.94%
DECK BuyDECKERS OUTDOOR CORP$12,407,000
+73.6%
224,000
+86.7%
2.94%
+28.0%
NVLNF NewNOVELION THERAPEUTICS INC$11,956,0001,420,000
+100.0%
2.83%
HBI NewHANESBRANDS INC$11,562,000536,000
+100.0%
2.74%
RXDX BuyIGNYTA INC$10,600,000
+15.1%
2,000,000
+36.6%
2.51%
-15.1%
HZNP NewHORIZON PHARMA PLC$10,517,000650,000
+100.0%
2.49%
SGYPQ BuySYNERGY PHARMACEUTICALS DEL$10,353,000
+51.5%
1,700,000
+37.1%
2.45%
+11.7%
WFM BuyWHOLE FOODS MKT INC$9,597,000
+69.3%
312,000
+56.0%
2.27%
+24.8%
TPX NewTEMPUR SEALY INTL INC$9,559,000140,000
+100.0%
2.26%
CPB NewCAMPBELL SOUP CO$9,554,000158,000
+100.0%
2.26%
VNDA BuyVANDA PHARMACEUTICALS INC$9,251,000
+1.1%
580,000
+5.5%
2.19%
-25.5%
ADMS NewADAMAS PHARMACEUTICALS INC$9,058,000536,000
+100.0%
2.14%
NOMD BuyNOMAD HLDGS LTD$8,613,000
+13.9%
900,000
+40.6%
2.04%
-16.1%
FLML BuyFLAMEL TECHNOLOGIES SAsponsored adr$8,603,000
+15.6%
828,000
+38.0%
2.04%
-14.7%
URBN NewURBAN OUTFITTERS INC$8,544,000300,000
+100.0%
2.02%
ACOR SellACORDA THERAPEUTICS INC$8,046,000
-29.7%
428,000
-21.9%
1.90%
-48.2%
AEO NewAMERICAN EAGLE OUTFITTERS NE$7,949,000524,000
+100.0%
1.88%
AET NewAETNA INC NEW$7,937,00064,000
+100.0%
1.88%
SHPG NewSHIRE PLCsponsored adr$7,837,00046,000
+100.0%
1.85%
TLRDQ BuyTAILORED BRANDS INC$7,665,000
+128.1%
300,000
+40.2%
1.81%
+68.2%
ENTA BuyENANTA PHARMACEUTICALS INC$7,638,000
+35.4%
228,000
+7.5%
1.81%
-0.2%
TSCO NewTRACTOR SUPPLY CO$7,581,000100,000
+100.0%
1.79%
SIG NewSIGNET JEWELERS LIMITED$5,844,00062,000
+100.0%
1.38%
JCPNQ NewPENNEY J C INC$5,817,000700,000
+100.0%
1.38%
SAM NewBOSTON BEER INCcl a$5,775,00034,000
+100.0%
1.37%
PII NewPOLARIS INDS INC$5,767,00070,000
+100.0%
1.36%
 PERNIX THERAPEUTICS HLDGS INdebt 4.250% 4/0$5,612,000
+16.1%
22,760,0000.0%1.33%
-14.4%
ABUS BuyARBUTUS BIOPHARMA CORP$4,753,000
-1.3%
1,940,000
+38.6%
1.12%
-27.2%
LOCO NewEL POLLO LOCO HLDGS INC$4,723,000384,000
+100.0%
1.12%
DLTR NewDOLLAR TREE INC$3,859,00050,000
+100.0%
0.91%
KATE SellKATE SPADE & CO$3,734,000
-45.5%
200,000
-50.0%
0.88%
-59.8%
ALIM BuyALIMERA SCIENCES INC$3,456,000
-6.2%
3,200,000
+29.4%
0.82%
-30.8%
BJRI NewBJS RESTAURANTS INC$3,458,00088,000
+100.0%
0.82%
NewDUNKIN BRANDS GROUP INCcall$3,146,00060,000
+100.0%
0.74%
BLUE NewBLUEBIRD BIO INC$2,468,00040,000
+100.0%
0.58%
HSGX BuyHISTOGENICS CORP$2,111,000
+147.8%
1,264,000
+376.3%
0.50%
+82.8%
DFRG NewDEL FRISCOS RESTAURANT GROUP$1,904,000112,000
+100.0%
0.45%
MDGL SellMADRIGAL PHARMACEUTICALS INC$1,848,000
+10.4%
124,000
-6.1%
0.44%
-18.6%
ROKA NewROKA BIOSCIENCE INC$1,001,000236,000
+100.0%
0.24%
ZSAN BuyZOSANO PHARMA CORP$936,000
+41.4%
1,200,000
+43.2%
0.22%
+4.2%
BLPH NewBELLEROPHON THERAPEUTICS INC$520,0001,000,000
+100.0%
0.12%
QLTI ExitQLT INC$0-1,115,455
-100.0%
-0.74%
BGFV ExitBIG 5 SPORTING GOODS CORP$0-178,000
-100.0%
-0.78%
TENX ExitTENAX THERAPEUTICS INC$0-1,068,000
-100.0%
-0.79%
TTPH ExitTETRA TECHNOLOGIES INC DEL$0-664,000
-100.0%
-0.82%
REPH ExitRECRO PHARMA INC$0-400,000
-100.0%
-1.14%
FIT ExitFITBIT INCcl a$0-250,000
-100.0%
-1.19%
AEGR ExitAEGERION PHARMACEUTICALS INC$0-1,292,000
-100.0%
-1.23%
TTWO ExitTAKE-TWO INTERACTIVE SOFTWAR$0-92,000
-100.0%
-1.33%
TGT ExitTARGET CORP$0-64,000
-100.0%
-1.41%
AAP ExitADVANCE AUTO PARTS INC$0-30,000
-100.0%
-1.44%
FLO ExitFLOWERS FOODS INC$0-316,000
-100.0%
-1.53%
ExitBEST BUY INC$0-136,000
-100.0%
-1.67%
MNRO ExitMONRO MUFFLER BRAKE INC$0-86,000
-100.0%
-1.69%
BWLD ExitBUFFALO WILD WINGS INC$0-40,000
-100.0%
-1.81%
THC ExitTENET HEALTHCARE CORP$0-264,000
-100.0%
-1.92%
SEAS ExitSEAWORLD ENTMT INC$0-528,000
-100.0%
-2.28%
PDLI ExitPDL BIOPHARMA INC$0-2,632,000
-100.0%
-2.83%
ExitVALEANT PHARMACEUTICALS INTLcall$0-360,000
-100.0%
-2.84%
PAY ExitVERIFONE SYS INC$0-564,000
-100.0%
-2.85%
Other managers

Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):

Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2017-02-15
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
ENANTA PHARMACEUTICALS INC30Q3 20232.7%
SPDR S&P 500 ETF TR28Q3 202329.5%
MADRIGAL PHARMACEUTICALS INC27Q3 20232.9%
VANDA PHARMACEUTICALS INC26Q3 20219.4%
REGENERON PHARMACEUTICALS25Q3 20233.2%
ENERGIZER HLDGS INC NEW22Q2 20233.7%
ANTARES PHARMA INC21Q3 20206.6%
INCYTE CORP21Q3 20232.8%
VOYAGER THERAPEUTICS INC21Q3 20232.0%
BLUEBIRD BIO INC20Q4 20211.8%

View ARMISTICE CAPITAL, LLC's complete holdings history.

Latest significant ownerships (13-D/G)
ARMISTICE CAPITAL, LLC Q4 2016 significant holdings filed using form 13D/G when ownership exceeds 5% of a company's total stock issue.
FiledShares Percentage
Avalo Therapeutics, Inc.June 28, 2023588,8504.7%
Addex Therapeutics Ltd.February 16, 2023675,2955.0%
Arcadia Biosciences, Inc.February 14, 20232,675,40910.0%
Avinger IncFebruary 14, 2023789,40010.0%
Baudax Bio, Inc.February 14, 20231,165,7095.0%
BIORA THERAPEUTICS, INC.February 14, 202312,989,6485.7%
Bit Digital, IncFebruary 14, 20233,161,8893.7%
Bruush Oral Care Inc.February 14, 20231,122,92210.0%
CATALYST PHARMACEUTICALS, INC.Sold outFebruary 14, 202300.0%
Clarus Therapeutics Holdings, Inc.February 14, 20232,732,1695.0%

View ARMISTICE CAPITAL, LLC's complete significant-ownership history.

Latest filings
TypeFiled
SC 13G/A2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14

View ARMISTICE CAPITAL, LLC's complete filings history.

Compare quarters

Export ARMISTICE CAPITAL, LLC's holdings